Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Endometriosis

3,4-methylenedioxyamphetamine has been researched along with Endometriosis in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.

Research Excerpts

ExcerptRelevanceReference
"An autocrine role of NGF in breast cancer and epithelial ovarian cancer (EOC) is evident now."1.35Neurotrophin in obstetrics and gynaecology. ( Bose, CK, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bose, CK1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Endometriosis

ArticleYear
Neurotrophin in obstetrics and gynaecology.
    Journal of stem cells, 2009, Volume: 4, Issue:4

    Topics: Animals; Breast Neoplasms; Embryo Implantation; Endometriosis; Female; Fetal Growth Retardation; Gyn

2009